DGAP-News: MeVis Medical Solutions AG / Key word(s): Statement/Offer
MeVis Medical Solutions AG: Path cleared for Varian acquisition of
majority stake of MeVis
12.03.2015 / 16:00
---------------------------------------------------------------------
VMS Deutschland Holdings GmbH waives Minimum Acceptance Threshold
- Acceptance Period extended to March 24th
- Transition of majority stake to Varian expected by mid-April
- Executive Board and Supervisory Board publish supplementary joint
statement on the amendment of the takeover offer
Bremen, March 12, 2015 - Executive Board and Supervisory Board of MeVis
Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical
imaging software, today published a supplementary joint reasoned statement
pursuant to § 27 Section 1 of the German Securities Acquisition and
Takeover Act (WpÃG) on the amendment of the voluntary public takeover offer
(cash offer) of VMS Deutschland Holdings GmbH published on March 9, 2015.
VMS Deutschland Holdings GmbH, based in Darmstadt, an affiliate of Varian
Medical Systems, Inc., Palo Alto, California, USA, published a voluntary
public takeover offer on January 27, 2015 to all shareholders of MeVis
Medical Solutions AG to acquire their registered non-par value shares
against payment of 17.50 Euros per share. The offer was subject to the
condition of a Minimum Acceptance Threshold of 75 % of the shares issued by
MeVis Medical Solutions AG (excluding treasury shares).
On March 9, 2015 VMS Deutschland Holdings GmbH has published an amendment
of the takeover over, waiving the Minimum Acceptance Threshold of 75 %.
Thus the offer is no longer subject to any conditions. The VMS Deutschland
Holdings GmbH is expected to acquire the majority stake by mid-April 2015.
Through the amendment of the takeover offer the Acceptance Period is
extended by two weeks to March 24, 2015, 12 pm.
The publication of the offer document and the amendment of the offer by VMS
Deutschland Holdings GmbH as well as further information, relevant to the
tender offer, are made available in the internet at
http://www.variango1.de.
Executive Board and Supervisory Board still welcome the offer and continue
to see Varian Medical Systems as a reliable partner for the further
development of MeVis Medical Solutions AG. They therefore also welcome the
amendment of the offer, as it increases the probability of a successful
execution of the offer.
"We are very pleased that there is now substantial certainty with regard to
the transaction, because Varian waived the Minimum Acceptance Threshold."
said Marcus Kirchhoff, CEO of MeVis Medical Solutions AG. Dr. Robert
Hannemann, CFO of MeVis Medical Solutions AG, added: "Since January 2014
our risk increased because of our strong dependency on our largest customer
Hologic. Now we assume that this risk will be significantly mitigated by
our future affiliation to a large market participant such as Varian."
The complete text of the supplementary joint reasoned statement is
published in the Internet at www.mevis.de under Investor Relations/ Aktie/
Ãbernahmeangebot in German language and is held available free of charge at
MeVis Medical Solutions AG, Investor Relations, Caroline Herschel-Strasse
1, 28359 Bremen, Tel: +49 (0)421-22495 0, Fax: +49 (0)421-22495 499,
E-mail: ir@mevis.de.
---------------------------------------------------------------------
12.03.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir@mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
332701 12.03.2015
DGAP-News: MeVis Medical Solutions AG: Path cleared for Varian acquisition of majority stake of MeVis
| Source: EQS Group AG